COMPOSITIONS OF BOSWELLIC ACIDS DERIVED FROM BOSWELLIA SERRATA GUM RESIN, FOR TREATING LYMPHOPROLIFERATIVE AND AUTOIMMUNE CONDITIONS

摘要

Method of treatment of lymphoproliferative and autoimmune disorders with a new composition of four boswellic acids including beta -boswellic acid, 3-O-acetyl- beta -boswellic acid, 11-keto- beta -boswellic acid, and 3-O-acetyl-11-keto- beta -boswellic acid. Boswellic acids of invention have been obtained in a novel industrial process from the gum resin of Boswellia serrata tree, providing standardized composition which inhibits DNA, RNA and protein synthesis of the target cell without cytotoxic effects. Composition of invention provides advantage of irreversible cytostatic therapy, equivalent to biological effects of a cytotoxic therapy without killing body cells.